The effectiveness of vaginal radiofrequency in preventing the prolapse of pelvic organs after surgery

A clinical trial to compare the effectiveness of the vaginal radiofrequency with placebo in preventing the prolapse of pelvic organs after surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220906055897N1

Enrollment

Registered

2022-10-08

Start date

2022-10-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse. Female genital prolapse

Interventions

Intervention 1: Intervention group: The intervention group will receive vaginal radiofrequency 6 weeks after prolapse surgery, then three sessions with a one-month interval. Radiofrequency is equipped

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with pelvic organ prolapse

Exclusion criteria

Exclusion criteria: Patients with active or recurrent genital infection (genital herpes, candidiasis) Recurrent urinary tract infection History of pelvic radiotherapy or vaginal brachytherapy History of reconstructive pelvic surgery

Design outcomes

Primary

Measure	Time frame
The degree of pelvic organ prolapse. Timepoint: Before, 6, 10, 14 and 18 weeks after surgery. Method of measurement: The pelvic organ prolapse quantifications system (POP-Q).;Quality of life. Timepoint: Before, 6, 10, 14 and 18 weeks after surgery. Method of measurement: Pelvic floor distress inventory (PFDI-20).	—

Secondary

Measure	Time frame
Sexual satisfaction. Timepoint: Before, 6, 10, 14 and 18 weeks after surgery. Method of measurement: The female sexual function index (FSFI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParivash Jelodarian

Tehran University of Medical Sciences

parivash1359@gmail.com+98 21 6119 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026